drugset / Trial / NCT01474915

Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

NCT01474915

Phase 4 Completed 122 enrolled Sergio Bergese
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is being done to determine the efficacies of two preventative drug combinations for postoperative nausea and vomiting in patients undergoing neurosurgery. The aim of this study is to compare the efficacy of using aprepitant instead of ondansetron in combination with dexamethasone and promethazine for post-operative nausea and vomiting prophylaxis. By completing this comparison study investigators will determine the most efficacious drug combination which will allow us to enhance the overall comfort and satisfaction of neurosurgical patients in the immediate postoperative period.

Timeline

Start
2007-06
Primary completion
2012-12
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aprepitant Other / unclassified 40 mg Oral
Comparator Ondansetron Other / unclassified 4 mg Intravenous
Comparator Dexamethasone Small molecule 10 mg Intravenous
Comparator Promethazine Small molecule 25 mg Intravenous

Indications

No indication recorded.